Revolutionizing Healthcare with Early Disease Detection
Quanterix, a company developing technology designed to enable earlier disease detection, made its market debut on Thursday. Shares of the company surged after pricing at $15 a share, and opening at $16.25 a share. Kevin Hrusovsky, CEO of Quanterix, was with us to discuss how the company plans to revolutionize healthcare.
The fourth-leading cause of death is drug side effects, and drugs only work half the time, says Hrusovsky. He believes that if you can personalize the drugs, you have an opportunity to improve the whole pharmaceutical industry.
Quanterix is developing technology that will digitize how they see into blood, and help to see disease long before there are symptoms. Rocket science is being deployed into the blood, says Hrusovsky. He says that if you can see biomarkers and incorporate into fitbits, it can really help improve health.
Visits to the emergency room related to mental health among young adults, teenagers, and children spiked between 2011 and 2020, according to the Journal of the American Medical Association. The annual number rose form 4.8 million to 7.5 million over that period.
A new study suggests water on Mars may be more widespread and recent than previously thought. Scientists reported the finding from China's Mars rover in Science Advances on Friday.
Thinking about trying a new diet but not sure which way to go? An evidence-based analysis of 10 popular eating patterns shows some promote heart health much better than others.
Camilla Marcus, founder of West-Bourne, joined Cheddar News to highlight the issue of wastefulness in the food industry and spoke on the importance of regenerative farming amid a growing climate crisis.
